Skip to search formSkip to main contentSkip to account menu

Chronic systolic heart failure

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Percutaneous renal artery denervation in patients with chronic systolic heart failure: A randomized controlled trial
Background Renal denervation (RDN) is as an effective treatment for heart failure (HF), but its effects on cardiac function of… 
Highly Cited
2014
Highly Cited
2014
Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT
Low systolic blood pressure (SBP) is associated with poor outcomes in heart failure and complicates management. In a post hoc… 
2013
2013
Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy.
2013
2013
Prognostic implications of relative hypochromia in ambulatory patients with chronic systolic heart failure.
Iron insufficiency has been associated with heart failure, but the impact of a reduction of hemoglobin content in the… 
2012
2012
Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure
AimTo evaluate the implementation of current pharmacotherapy guidelines of heart failure and to identify factors associated with… 
2012
2012
Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study.
Review
2011
Review
2011
Efficacy of statin therapy in chronic systolic cardiac insufficiency: a meta-analysis.
2010
2010
Simultaneous Assessment of Unprocessed ProBNP1-108 in Addition to Processed BNP32 Improves Identification of High-Risk Ambulatory Patients With Heart Failure
Background—B-type natriuretic peptide (BNP) is produced as a biologically inactive prohormone (proBNP1-108), processed, and… 
Review
2008
Review
2008
Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy
BackgroundThere is robust evidence for effective pharmacotherapy of chronic (systolic) heart failure (CHF) which has led to the… 
2004
2004
Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.
BACKGROUND AND METHODS Loop diuretic therapy is an essential part of chronic systolic heart failure (CH)F management, yet… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)